Report Overview
The HIV/AIDS testing market encompasses diagnostic products and services designed to detect the human immunodeficiency virus (HIV) and monitor its progression, including rapid tests, laboratory-based assays, and self-testing kits. These tests are critical for early diagnosis, treatment initiation, and prevention of transmission, with demand driven by global public health initiatives, rising awareness, and increasing government funding for screening programs. The market is segmented by test type (antibody, antigen, nucleic acid tests), sample type (blood, oral fluid, urine), and end-user (hospitals, diagnostic labs, home care settings). Key growth factors include advancements in testing technologies, the expansion of at-home testing options, and the rising prevalence of HIV in high-burden regions such as Sub-Saharan Africa. However, challenges such as stigma, limited healthcare access in low-income areas, and regulatory hurdles in some markets may restrain growth. Major players include Abbott Laboratories, Roche Diagnostics, and OraSure Technologies, who are investing in innovation and partnerships to improve accessibility and accuracy. The market is also influenced by trends like telemedicine integration and AI-driven diagnostics, which are expected to shape future demand.
The global Hiv Aids Testing market size was estimated at USD 410.32 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 5.20% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hiv Aids Testing market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hiv Aids Testing market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hiv Aids Testing market.
Global Hiv Aids Testing Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Lonza
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Market Segmentation (by Type)
Kits and Reagents
Instruments
Others
Market Segmentation (by Application)
Hospitals
Private Diagnostics Laboratories
Academic and Research Institutes
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hiv Aids Testing Market
Overview of the regional outlook of the Hiv Aids Testing Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hiv Aids Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market\'s competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter\'s five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hiv Aids Testing, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Hiv Aids Testing
1.2 Key Market Segments
1.2.1 Hiv Aids Testing Segment by Type
1.2.2 Hiv Aids Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Hiv Aids Testing Market Overview
2.1 Global Market Overview
2.1.1 Global Hiv Aids Testing Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Hiv Aids Testing Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Hiv Aids Testing Market Competitive Landscape
3.1 Company Assessment Quadrant
3.2 Global Hiv Aids Testing Product Life Cycle
3.3 Global Hiv Aids Testing Sales by Manufacturers (2020-2025)
3.4 Global Hiv Aids Testing Revenue Market Share by Manufacturers (2020-2025)
3.5 Hiv Aids Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hiv Aids Testing Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Hiv Aids Testing Market Competitive Situation and Trends
3.8.1 Hiv Aids Testing Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hiv Aids Testing Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 Hiv Aids Testing Industry Chain Analysis
4.1 Hiv Aids Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Hiv Aids Testing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hiv Aids Testing Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hiv Aids Testing Market
5.7 ESG Ratings of Leading Companies
6 Hiv Aids Testing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hiv Aids Testing Sales Market Share by Type (2020-2025)
6.3 Global Hiv Aids Testing Market Size Market Share by Type (2020-2025)
6.4 Global Hiv Aids Testing Price by Type (2020-2025)
7 Hiv Aids Testing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hiv Aids Testing Market Sales by Application (2020-2025)
7.3 Global Hiv Aids Testing Market Size (M USD) by Application (2020-2025)
7.4 Global Hiv Aids Testing Sales Growth Rate by Application (2020-2025)
8 Hiv Aids Testing Market Sales by Region
8.1 Global Hiv Aids Testing Sales by Region
8.1.1 Global Hiv Aids Testing Sales by Region
8.1.2 Global Hiv Aids Testing Sales Market Share by Region
8.2 Global Hiv Aids Testing Market Size by Region
8.2.1 Global Hiv Aids Testing Market Size by Region
8.2.2 Global Hiv Aids Testing Market Size Market Share by Region
8.3 North America
8.3.1 North America Hiv Aids Testing Sales by Country
8.3.2 North America Hiv Aids Testing Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hiv Aids Testing Sales by Country
8.4.2 Europe Hiv Aids Testing Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hiv Aids Testing Sales by Region
8.5.2 Asia Pacific Hiv Aids Testing Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hiv Aids Testing Sales by Country
8.6.2 South America Hiv Aids Testing Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hiv Aids Testing Sales by Region
8.7.2 Middle East and Africa Hiv Aids Testing Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 Hiv Aids Testing Market Production by Region
9.1 Global Production of Hiv Aids Testing by Region(2020-2025)
9.2 Global Hiv Aids Testing Revenue Market Share by Region (2020-2025)
9.3 Global Hiv Aids Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hiv Aids Testing Production
9.4.1 North America Hiv Aids Testing Production Growth Rate (2020-2025)
9.4.2 North America Hiv Aids Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hiv Aids Testing Production
9.5.1 Europe Hiv Aids Testing Production Growth Rate (2020-2025)
9.5.2 Europe Hiv Aids Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hiv Aids Testing Production (2020-2025)
9.6.1 Japan Hiv Aids Testing Production Growth Rate (2020-2025)
9.6.2 Japan Hiv Aids Testing Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hiv Aids Testing Production (2020-2025)
9.7.1 China Hiv Aids Testing Production Growth Rate (2020-2025)
9.7.2 China Hiv Aids Testing Production, Revenue, Price and Gross Margin (2020-2025)
10 Key Companies Profile
10.1 Abbott
10.1.1 Abbott Basic Information
10.1.2 Abbott Hiv Aids Testing Product Overview
10.1.3 Abbott Hiv Aids Testing Product Market Performance
10.1.4 Abbott Business Overview
10.1.5 Abbott SWOT Analysis
10.1.6 Abbott Recent Developments
10.2 Affymetrix
10.2.1 Affymetrix Basic Information
10.2.2 Affymetrix Hiv Aids Testing Product Overview
10.2.3 Affymetrix Hiv Aids Testing Product Market Performance
10.2.4 Affymetrix Business Overview
10.2.5 Affymetrix SWOT Analysis
10.2.6 Affymetrix Recent Developments
10.3 Beckman Coulter/Danaher
10.3.1 Beckman Coulter/Danaher Basic Information
10.3.2 Beckman Coulter/Danaher Hiv Aids Testing Product Overview
10.3.3 Beckman Coulter/Danaher Hiv Aids Testing Product Market Performance
10.3.4 Beckman Coulter/Danaher Business Overview
10.3.5 Beckman Coulter/Danaher SWOT Analysis
10.3.6 Beckman Coulter/Danaher Recent Developments
10.4 Becton Dickinson
10.4.1 Becton Dickinson Basic Information
10.4.2 Becton Dickinson Hiv Aids Testing Product Overview
10.4.3 Becton Dickinson Hiv Aids Testing Product Market Performance
10.4.4 Becton Dickinson Business Overview
10.4.5 Becton Dickinson Recent Developments
10.5 bioMerieux
10.5.1 bioMerieux Basic Information
10.5.2 bioMerieux Hiv Aids Testing Product Overview
10.5.3 bioMerieux Hiv Aids Testing Product Market Performance
10.5.4 bioMerieux Business Overview
10.5.5 bioMerieux Recent Developments
10.6 Bio-Rad
10.6.1 Bio-Rad Basic Information
10.6.2 Bio-Rad Hiv Aids Testing Product Overview
10.6.3 Bio-Rad Hiv Aids Testing Product Market Performance
10.6.4 Bio-Rad Business Overview
10.6.5 Bio-Rad Recent Developments
10.7 Cepheid
10.7.1 Cepheid Basic Information
10.7.2 Cepheid Hiv Aids Testing Product Overview
10.7.3 Cepheid Hiv Aids Testing Product Market Performance
10.7.4 Cepheid Business Overview
10.7.5 Cepheid Recent Developments
10.8 Diamedix
10.8.1 Diamedix Basic Information
10.8.2 Diamedix Hiv Aids Testing Product Overview
10.8.3 Diamedix Hiv Aids Testing Product Market Performance
10.8.4 Diamedix Business Overview
10.8.5 Diamedix Recent Developments
10.9 DiaSorin
10.9.1 DiaSorin Basic Information
10.9.2 DiaSorin Hiv Aids Testing Product Overview
10.9.3 DiaSorin Hiv Aids Testing Product Market Performance
10.9.4 DiaSorin Business Overview
10.9.5 DiaSorin Recent Developments
10.10 Eiken Chemical
10.10.1 Eiken Chemical Basic Information
10.10.2 Eiken Chemical Hiv Aids Testing Product Overview
10.10.3 Eiken Chemical Hiv Aids Testing Product Market Performance
10.10.4 Eiken Chemical Business Overview
10.10.5 Eiken Chemical Recent Developments
10.11 Elitech Group
10.11.1 Elitech Group Basic Information
10.11.2 Elitech Group Hiv Aids Testing Product Overview
10.11.3 Elitech Group Hiv Aids Testing Product Market Performance
10.11.4 Elitech Group Business Overview
10.11.5 Elitech Group Recent Developments
10.12 Enzo Biochem
10.12.1 Enzo Biochem Basic Information
10.12.2 Enzo Biochem Hiv Aids Testing Product Overview
10.12.3 Enzo Biochem Hiv Aids Testing Product Market Performance
10.12.4 Enzo Biochem Business Overview
10.12.5 Enzo Biochem Recent Developments
10.13 Fujirebio
10.13.1 Fujirebio Basic Information
10.13.2 Fujirebio Hiv Aids Testing Product Overview
10.13.3 Fujirebio Hiv Aids Testing Product Market Performance
10.13.4 Fujirebio Business Overview
10.13.5 Fujirebio Recent Developments
10.14 Lonza
10.14.1 Lonza Basic Information
10.14.2 Lonza Hiv Aids Testing Product Overview
10.14.3 Lonza Hiv Aids Testing Product Market Performance
10.14.4 Lonza Business Overview
10.14.5 Lonza Recent Developments
10.15 Roche
10.15.1 Roche Basic Information
10.15.2 Roche Hiv Aids Testing Product Overview
10.15.3 Roche Hiv Aids Testing Product Market Performance
10.15.4 Roche Business Overview
10.15.5 Roche Recent Developments
10.16 Scienion
10.16.1 Scienion Basic Information
10.16.2 Scienion Hiv Aids Testing Product Overview
10.16.3 Scienion Hiv Aids Testing Product Market Performance
10.16.4 Scienion Business Overview
10.16.5 Scienion Recent Developments
10.17 Sequenom
10.17.1 Sequenom Basic Information
10.17.2 Sequenom Hiv Aids Testing Product Overview
10.17.3 Sequenom Hiv Aids Testing Product Market Performance
10.17.4 Sequenom Business Overview
10.17.5 Sequenom Recent Developments
10.18 SeraCare
10.18.1 SeraCare Basic Information
10.18.2 SeraCare Hiv Aids Testing Product Overview
10.18.3 SeraCare Hiv Aids Testing Product Market Performance
10.18.4 SeraCare Business Overview
10.18.5 SeraCare Recent Developments
10.19 Siemens
10.19.1 Siemens Basic Information
10.19.2 Siemens Hiv Aids Testing Product Overview
10.19.3 Siemens Hiv Aids Testing Product Market Performance
10.19.4 Siemens Business Overview
10.19.5 Siemens Recent Developments
10.20 Takara Bio
10.20.1 Takara Bio Basic Information
10.20.2 Takara Bio Hiv Aids Testing Product Overview
10.20.3 Takara Bio Hiv Aids Testing Product Market Performance
10.20.4 Takara Bio Business Overview
10.20.5 Takara Bio Recent Developments
11 Hiv Aids Testing Market Forecast by Region
11.1 Global Hiv Aids Testing Market Size Forecast
11.2 Global Hiv Aids Testing Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hiv Aids Testing Market Size Forecast by Country
11.2.3 Asia Pacific Hiv Aids Testing Market Size Forecast by Region
11.2.4 South America Hiv Aids Testing Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hiv Aids Testing by Country
12 Forecast Market by Type and by Application (2026-2033)
12.1 Global Hiv Aids Testing Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Hiv Aids Testing by Type (2026-2033)
12.1.2 Global Hiv Aids Testing Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Hiv Aids Testing by Type (2026-2033)
12.2 Global Hiv Aids Testing Market Forecast by Application (2026-2033)
12.2.1 Global Hiv Aids Testing Sales (K Units) Forecast by Application
12.2.2 Global Hiv Aids Testing Market Size (M USD) Forecast by Application (2026-2033)
13 Conclusion and Key Findings
